CYTOF — Altamira Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual balance sheet for Altamira Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	R2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	20-F	20-F	20-F	20-F	20-F/A
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	fx Final	fx Final	fx Final	fx Final	fx Final
Cash
Cash and Equivalents
Cash and Short Term Investments	1.43	12.7	1.08	0.017	0.583
Net Total Accounts Receivable
Net Total Receivables	0.346	0.091	0.76	0.825	0.455
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	2.45	13.1	4.49	1.91	1.64
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.069	0.053	0.619	0.482	—
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	9.53	23.5	21	6.82	1.76
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2.35	3.42	5.33	13.9	0.693
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	3.3	4.55	6.72	15.8	1.87
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	6.24	18.9	14.3	-8.99	-0.111
Total Liabilities & Shareholders' Equity	9.53	23.5	21	6.82	1.76
Total Common Shares Outstanding